AUG 26·SEC EDGARLow
Crotty Dylan Bram sold $145K of SYK (indirect holdings)
Crotty Dylan Bram (Group President) sold 441 indirectly-held shares of STRYKER CORP (SYK) at $328.60 ($0.14M total) on 2026-08-21.
StockNYSE · US · USDHealthcare · Medical Devices
$SYK
STRYKER CORP
alphai earnings readsecond quarter 2026 · JUL 30STRYKER REPORTS SECOND QUARTER 2026 OPERATING RESULTSVerdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $SYKvia TradingView
AI sentiment · 7d1 articles
- Bullish
- 1
- Neutral
- 0
- Bearish
- 0
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $118.2M 22 txs
STRYKER RONDA E20× · $117.8M
10b5-1 share of filings0%
Top stories · $SYKMore →
AUG 24·thedefensepost.com
Argentina Secures Buy of 235 Stryker Vehicles From US
Argentina has agreed to buy 235 Stryker 8×8 armored vehicles from the US, including infantry carriers, command posts, and medical evacuation variants. The deal, part of US defense programs, will modernize the Argentine Army's mechanized forces. Initial deliveries of 50 vehicles are expected after technical inspections. The Strykers, originally developed by General Dynamics, offer various armament options and protection features.
AUG 21·yahoo.com
Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?
Analysts covering Stryker (SYK) stock have a consensus 'Strong Buy' rating, with 19 'Strong Buy' ratings, 3 'Moderate Buys,' and 7 'Holds.' Citi raised its price target to $399, citing optimism about the medtech sector. The mean price target is $379.81, a 11.7% premium to the current price.
SYK sentiment & insider activity
Over the past 7 days, alphai's AI scored 1 news story mentioning SYK (STRYKER CORP). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent SYK coverage spans financial news, insider activity and market movers.
In the last 30 days, SYK insiders filed 22 SEC Form 4 transactions — no purchases and 22 sales ($118.2M). The most active reporter was STRYKER RONDA E with 20 filings.
What's driving SYK
Minor insider sell; unlikely to move price materially.
Argentina has agreed to buy 235 Stryker 8×8 armored vehicles from the US, including infantry carriers, command posts, and medical evacuation variants. The deal, part of US defense programs, will modernize the Argentine Army's mechanized forces. Initial deliveries of 50 vehicles are expected after technical inspections. The Strykers, originally developed by General Dynamics, offer various armament options and protection features.
The upward price target suggests potential upside for SYK, supporting a bullish stance.
No immediate price impact expected; the piece reiterates known information.
Large insider sell may signal bearish sentiment, but limited immediate price impact.
alphai scores every news story that mentions SYK with an AI model for sentiment and relevance, and aggregates insider trades from STRYKER CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $SYK
Score
Crotty Dylan Bram sold $145K of SYK (indirect holdings)
Crotty Dylan Bram (Group President) sold 441 indirectly-held shares of STRYKER CORP (SYK) at $328.60 ($0.14M total) on 2026-08-21.
1 min read
Argentina Secures Buy of 235 Stryker Vehicles From US
Argentina has agreed to buy 235 Stryker 8×8 armored vehicles from the US, including infantry carriers, command posts, and medical evacuation variants. The deal, part of US defense programs, will modernize the Argentine Army's mechanized forces. Initial deliveries of 50 vehicles are expected after technical inspections. The Strykers, originally developed by General Dynamics, offer various armament options and protection features.
2 min read
Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?
Analysts covering Stryker (SYK) stock have a consensus 'Strong Buy' rating, with 19 'Strong Buy' ratings, 3 'Moderate Buys,' and 7 'Holds.' Citi raised its price target to $399, citing optimism about the medtech sector. The mean price target is $379.81, a 11.7% premium to the current price.
1 min read
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker (SYK) faced cyber disruptions in 2026 but showed strong demand, robotics adoption, and international growth. Q2 2026 saw 9% organic sales growth, with MedSurg & Neurotechnology up 9.2% and Orthopaedics up 8.6%. Mako robotics drove growth, with over 2.5 million procedures globally. Adjusted EPS rose 17.9% to $3.69, with margin expansion. However, cybersecurity costs and supply disruptions weighed on performance. SYK's stock is down 6.7% YTD, with a $125.7B market cap and expected 10.4% ea
3 min read
Stryker Board Member Sold $117.78M In Company Stock - Stryker (NYSE:SYK)
Stryker (NYSE:SYK) board member Ronda E. Stryker sold 350,000 shares, totaling $117.78M, according to an SEC filing. Stryker's stock rose 0.87% to $327.01. The company reported 9.42% revenue growth and a 68.27% gross margin, but has a high debt-to-equity ratio of 0.62 and overvalued P/E and P/S ratios.
2 min readSTRYKER RONDA E sold $117.8M of SYK (indirect holdings)
STRYKER RONDA E sold 350,000 indirectly-held shares of STRYKER CORP (SYK) at an average of $336.50 ($331.74–$343.47, $117.78M total) across 20 trades over 2026-08-18 to 2026-08-19.
1 min read
Stocks making big moves yesterday: Wendy's, Equifax, Jack Henry, PulteGroup, and Stryker
Wendy's (WEN) +5% on private equity interest; Equifax (EFX) +6.4% after dividend declaration; Jack Henry (JKHY) +7.4% on earnings beat; PulteGroup (PHM) +4.6% on analyst rating; Stryker (SYK) +2.7% on $100M contract.
2 min read
Why Stryker (SYK) Stock Is Trading Up Today
Stryker (SYK) shares rose 2.7% after its Stryker Sales unit secured a $100M contract modification from the US Defense Logistics Agency. The stock closed at $340.05, up 2.6% from the previous close. The company reported a 9.4% year-on-year revenue increase to $6.59B in Q2 but missed organic sales growth expectations.
2 min readKing Debra sold $278K of SYK
King Debra (See Remarks) sold 826 shares of STRYKER CORP (SYK) at $336.30 ($0.28M total) on 2026-08-18.
1 min readWolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
Wolfe Research downgraded Stryker (SYK) to Peer Perform, citing a difficult second-half outlook after a March cyber disruption and noting the June quarter did not fully catch up. Wolfe said Stryker’s guidance implies 54% of revenue in 2H. Wolfe upgraded Abbott (ABT) to Outperform with a $130 target, citing better 2027 catalysts.
2 min read